These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Immunophenotypic characteristics of the blast crisis in chronic myeloid leukemia. López-Karpovitch X; Cárdenas R; Piedras J Rev Invest Clin; 1997; 49(1):31-6. PubMed ID: 9229753 [TBL] [Abstract][Full Text] [Related]
26. Expression of two natural killer cell antigens, H-25 and H-366, by human immature myeloid cells and by erythroid and granulocytic/monocytic colony-forming units. Wisniewski D; Knowles R; Wachter M; Strife A; Clarkson B Blood; 1987 Feb; 69(2):419-29. PubMed ID: 2948578 [TBL] [Abstract][Full Text] [Related]
28. Expression of MY7 antigen on myeloid precursor cells. Griffin JD; Ritz J; Beveridge RP; Lipton JM; Daley JF; Schlossman SF Int J Cell Cloning; 1983 Apr; 1(1):33-48. PubMed ID: 6585426 [TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibodies raised against K562 cells reacted with human haematopoietic pluripotent stem cells. Kubota Y; Tanaka T; Irino S Leuk Res; 1991; 15(4):195-204. PubMed ID: 2030600 [TBL] [Abstract][Full Text] [Related]
30. T lymphocytes cultured from chronic myelogenous leukemia bone marrow suppress autologous hematopoietic progenitors. Bhatia R; McGlave PB Leukemia; 1995 Jun; 9(6):1006-12. PubMed ID: 7596165 [TBL] [Abstract][Full Text] [Related]
31. A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity. Mori T; Sugita K; Suzuki T; Okazaki T; Manabe A; Hosoya R; Mizutani S; Kinoshita A; Nakazawa S Leukemia; 1995 Jul; 9(7):1233-9. PubMed ID: 7543176 [TBL] [Abstract][Full Text] [Related]
32. MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies. Filshie RJ; Zannettino AC; Makrynikola V; Gronthos S; Henniker AJ; Bendall LJ; Gottlieb DJ; Simmons PJ; Bradstock KF Leukemia; 1998 Mar; 12(3):414-21. PubMed ID: 9529137 [TBL] [Abstract][Full Text] [Related]
33. Antigenic phenotype of chronic granulocytic leukaemia progenitor cells in chronic phase and in blastic transformation characterized by means of monoclonal antibodies. Robak T Arch Immunol Ther Exp (Warsz); 1988; 36(4):471-85. PubMed ID: 3074744 [TBL] [Abstract][Full Text] [Related]
34. Expression of myeloid differentiation antigens on normal and chronic granulocytic leukemia erythroid progenitor cells identified by monoclonal antibodies. Robak T Arch Immunol Ther Exp (Warsz); 1987; 35(4):519-29. PubMed ID: 3481543 [TBL] [Abstract][Full Text] [Related]
37. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. Wisniewski D; Strife A; Atzpodien J; Clarkson BD Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231 [TBL] [Abstract][Full Text] [Related]
38. RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. Atkins GJ; Kostakis P; Vincent C; Farrugia AN; Houchins JP; Findlay DM; Evdokiou A; Zannettino AC J Bone Miner Res; 2006 Sep; 21(9):1339-49. PubMed ID: 16939392 [TBL] [Abstract][Full Text] [Related]
39. An antigen shared by human granulocytes, monocytes, marrow granulocyte precursors and leukemic blasts. Shumak KH; Rachkewich RA Acta Haematol; 1983; 69(3):164-70. PubMed ID: 6404099 [TBL] [Abstract][Full Text] [Related]